Prostate cancer onset and progression are closely correlated with the androgen receptor (AR) activity [2, 3] The activation of AR is mediated by androgens, whose synthesis is regulated by the hypothalamic–pituitary–testicular (HPT) axis [4]. This evidence concerns the gene AR and prostate carcinoma.